Analyst Ratings For Celgene (NASDAQ:CELG)
Today, BMO Capital Markets reiterated its Buy rating on Celgene (NASDAQ:CELG) with a price target of $144.00.
Some recent analyst ratings include
- 1/24/2018-BMO Capital Markets Reiterated Rating of Buy.
- 1/23/2018-Royal Bank of Canada Reiterated Rating of Top Pick.
- 1/23/2018-BTIG Research Reiterated Rating of Hold.
- 1/18/2018-Piper Jaffray Companies Reiterated Rating of Hold.
- 1/17/2018-Mizuho Reiterated Rating of Buy.
- 1/10/2018-Guggenheim Reiterated Rating of Buy.
Recent Insider Trading Activity For Celgene (NASDAQ:CELG)
Celgene (NASDAQ:CELG) has insider ownership of 0.95% and institutional ownership of 79.54%.
- On 9/25/2017 Terrie Curran, Insider, sold 1,727 with an average share price of $143.89 per share and the total transaction amounting to $248,498.03.
- On 9/12/2017 Gilla Kaplan, Director, sold 9,250 with an average share price of $141.56 per share and the total transaction amounting to $1,309,430.00.
- On 9/5/2017 Michael D Casey, Director, sold 9,250 with an average share price of $139.03 per share and the total transaction amounting to $1,286,027.50.
- On 8/10/2017 Ernest Mario, Director, sold 18,506 with an average share price of $130.52 per share and the total transaction amounting to $2,415,403.12.
- On 8/2/2017 Gilla Kaplan, Director, sold 7,500 with an average share price of $134.52 per share and the total transaction amounting to $1,008,900.00.
- On 6/26/2017 James J Loughlin, Director, sold 18,500 with an average share price of $133.57 per share and the total transaction amounting to $2,471,045.00.
- On 6/22/2017 Michael A Friedman, Director, sold 10,000 with an average share price of $132.50 per share and the total transaction amounting to $1,325,000.00.
Recent Trading Activity for Celgene (NASDAQ:CELG)
Shares of Celgene closed the previous trading session at 104.93 up +0.38 0.36% with 104.97000122070312 shares trading hands.